We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Why talking may not always be the best solution, plus the Office Therapy advice column
Everyone seems to want a piece of the sweathouse action
Ecommerce giant aims to widen its reach into $4tn industry
The condition can be debilitating at work – and medicines are in short supply globally
German group slashes guidance by €1bn and reduces spending as it expects fewer first vaccine doses and lower boosting
Findings show need to mitigate growing risks posed by animal-to-human pathogens such as coronaviruses
Findings could boost development of medical technology such as brain-machine interfaces
Biotech blames weaker US sales after lowering full-year forecast
Danish group has expanded manufacturing capacity but says demand will continue to outstrip supply
Caroline Reed’s job is to create art so realistic that no one notices it
First jab for respiratory syncytial virus powers sales at UK drugmaker
Further research on its underlying causes and preventive action is essential
Survey of 1,000 companies lays bare worries about impact of long NHS waiting lists on workforce productivity
Domestically made products like syringes currently cost more than those produced in China
Emerging research is challenging a widely held belief that new cases of the condition will rise exponentially as people live longer
Tyres release many more polluting particles than an exhaust pipe but rarely come under scrutiny
UK Biobank’s records of 500,000 people promise breakthroughs in diseases and ageing
Fear of ageing is nothing new. But it’s happening younger and younger
Market’s dim view of sector’s growth prospects may be overdone
How to pack the ultimate in luxury travel
Strains are particularly acute in areas of high deprivation
Proposed changes to work capability assessment could be centrepiece of push to cut welfare bill in Autumn Statement
Pioneering medicines developed by Eisai and Eli Lilly shown to be more effective when taken earlier
Failure to grant extra funding in Autumn Statement would be ‘self-destructive’, head of King’s Fund think-tank says
NHS has made ‘poor use’ of resources but government’s long-term staffing plan is ‘unfunded and uncosted’, committee finds
International Edition
-50fb56c8-7dba-40d5-8503-10cacf20b6d8.jpeg?source=next&fit=scale-down&dpr=2&width=240)
